Terrific data for pasritamig and JNJ-9401 at #SITC2026. Excellent presentation by @LauraGrahamMD. Honored to be part of this study and so grateful to the patients and team @columbiacancer@ColumbiaMed@nyphospital who make these important advances possible.
There’s still time to vote for ASCO nominating committee - good friend and great leader in oncology @PGrivasMDPhD is a candidate who would make great contributions asco.org/about-asco/asco-ove…
Happening now - ASCO elections! @montypal has worked tirelessly through ASCO committees and now as president of MOASC to accelerate progress in cancer research and treatment. View all candidates and bios and vote now! Asco.org/elections
Dual-antigen T-cell engagement demonstrates encouraging clinical activity in advanced prostate cancer.
At #SITC26, Laura Graham, MD of @CUDeptMedicine presents phase 1 results showing substantial PSA reductions and a manageable safety profile with combined KLK2 and PSMA targeting. #MoffittSITC26